Stereotactic Radiation Potential Emerges in Prostate Cancer

Michael Folkert, MD, PhD
Published: Wednesday, Sep 28, 2016
UT Southwestern Medical CenterLorraine Pelosof, MD, PhD
Michael Folkert, MD, PhD
Assistant Professor

Radiation Oncology

UT Southwestern Medical Center

Dallas, TX
Strategic Partners
With widespread use of prostate-specific antigen (PSA) screening, a majority of newly diagnosed prostate cancers are confined to the organ and are typically treated with radical prostatectomy or radiotherapy.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication